PEBP1 and prostate cancer: Histone modifications: In the prostate cancer cell line DU145, the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) caused a potent increase in RKIP levels [25], raising the possibility that histone deacetylation might play a role in RKIP silencing.